RecruitingNot ApplicableNCT06372288

Theta Burst TMS for Treatment of Methamphetamine Use Disorder

Theta Burst Transcranial Magnetic Stimulation for the Treatment of Methamphetamine Use Disorder


Sponsor

Carilion Clinic

Enrollment

40 participants

Start Date

Dec 20, 2023

Study Type

INTERVENTIONAL

Summary

This study is using Transcranial Magnetic Stimulation (TMS) to determine if interventional psychiatry treatment can help with the treatment of Methamphetamine Use Disorder. Individuals with Methamphetamine Use Disorder will receive 5 consecutive TMS treatment sessions based off of randomization. Participants will be randomized to one of two groups. TMS treatment arm or sham-TMS arm.


Eligibility

Min Age: 18 YearsMax Age: 55 Years

Inclusion Criteria2

  • Individuals actively struggling with Methamphetamine Use Disorder
  • Must be currently enrolled in Carilion Clinic Office Based Addiction Treatment (OBAT) program

Exclusion Criteria1

  • \- Individuals currently struggling with alcohol use and/or benzodiazepine use

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscranial Magnetic Stimulation

Transcranial Magnetic Stimulation (TMS using Intermittent theta burst stimulation (iTBS)

DEVICESham Transcranial Magnetic Stimulation

Participants will not receive intermittent theta burst stimulation during the sham-TMS sessions


Locations(1)

Carilion Clinic

Roanoke, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06372288